![Onaiza Cadoret-Manier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Onaiza Cadoret-Manier
Directeur/Membre du Conseil chez
ARDELYX, INC.
Fortune : 881 872 $ au 31/07/2026
Profil
Onaiza Cadoret-Manier is currently Chief Executive Officer at Yemaya, Inc. and Independent Director at Ardelyx, Inc. since 2020.
Former roles include Chief Executive Officer at Stealth Mode Biotech, Independent Director at Ventyx Biosciences, Inc. from 2023 to 2026, Vice President-Respiratory Franchise at Genentech, Inc. from 2011 to 2018, Chief Commercial Officer at GRAIL, Inc. and Grail Biosciences from 2018 to 2019, and EVP, Chief Product Strategy & Operations Officer at Ionis Pharmaceuticals, Inc. from 2022 to 2024.
Education includes an undergraduate degree from Queens College in 1985 and an MBA from The University of Chicago in 1989.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARDELYX, INC. 0,07% | 16/06/2026 | 178 156 ( 0,07% ) | 881 872 $ | 31/07/2026 |
Postes actifs de Onaiza Cadoret-Manier
| Sociétés | Poste | Début |
|---|---|---|
| ARDELYX, INC. | Directeur/Membre du Conseil | 12/03/2020 |
Anciens postes connus de Onaiza Cadoret-Manier
| Sociétés | Poste | Fin |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Directeur/Membre du Conseil | 04/03/2026 |
| IONIS PHARMACEUTICALS, INC. | Directeur des opérations | 15/03/2024 |
| GRAIL, INC. | Corporate Officer/Principal | 01/05/2019 |
Grail Biosciences | Corporate Officer/Principal | 01/01/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/05/2018 |
Formation de Onaiza Cadoret-Manier
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Queens College
 Queens College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
GRAIL, Inc.
 GRAIL, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection test kits and provides related services | Health Technology |
Grail Biosciences | |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
